Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Nippon India Pharma Fund · Regular ✕Axis ESG Integration Strategy Fund · Regular ✕

Growth of ₹10,000

Basics

Nippon India Pharma FundAxis ESG Integration Strategy Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseNippon IndiaAxis
NAV₹591.2429₹21.0800
NAV date20 Nov 202620 Nov 2026
History20.6 years6.8 years
Expense ratio1.8%2.6%
Stars★★★★★★★★★★
Growth Score78.1028.20

Returns

Nippon India Pharma FundAxis ESG Integration Strategy Fund
1 month+11.32%+6.63%
3 months+3.52%−0.38%
6 months+8.09%+3.89%
YTD+16.05%−3.88%
1 year+14.27%−3.92%
3 years (CAGR)+16.91%+7.49%
5 years (CAGR)+14.37%+4.29%
10 years (CAGR)+15.58%—
Since launch+17.64%+11.50%

Risk

Nippon India Pharma FundAxis ESG Integration Strategy Fund
Volatility14.1%14.0%
Downside volatility9.1%10.4%
Sharpe0.740.07
Sortino1.150.10
Calmar1.140.40
Return / risk1.200.53
Deepest fall−47.36%−25.09%
Days to recover301531
Below its high+0.00%−9.45%

Against benchmark

Nippon India Pharma FundAxis ESG Integration Strategy Fund
Alpha−2.75%—
Beta0.89—
R²89.5%—
Up capture83.5%—
Down capture91.2%—
Tracking error4.8%—
Information ratio−0.88—
Treynor0.11—

Consistency

Nippon India Pharma FundAxis ESG Integration Strategy Fund
Best 1-year+175.79%+67.94%
Middle 1-year+13.84%+8.07%
Worst 1-year−36.67%−17.67%
1-year periods with a loss23.4%31.3%
Middle 3-year+20.93%+11.69%
Positive months63.9%63.9%
Best day+3.40%+3.73%
Worst day−3.21%−3.59%
Worst 5% day−1.38%−1.23%
Positive days53.7%51.4%
NAVs a year247251

SIP of ₹10,000 a month

Nippon India Pharma FundAxis ESG Integration Strategy Fund
5-year XIRR+17.18%+6.26%
5-year value₹9,29,284₹7,05,168
3-year XIRR+13.26%+2.23%
1-year XIRR+21.05%+1.90%

Holdings overlap i

Nippon India Pharma FundAxis ESG Integration Strategy Fund
Nippon India Pharma Fund—8%
Axis ESG Integration Strategy Fund8%—

Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.

Held by all of them

StockNippon India Pharma FundAxis ESG Integration Strategy Fund
Sun Pharmaceutical Industries Limited11.55%2.77%
IPCA Laboratories Limited2.90%1.35%
Anthem Biosciences Limited1.30%1.67%
Biocon Limited0.97%2.29%
Alkem Laboratories Limited1.82%0.73%
Gland Pharma Limited2.73%0.39%

Sectors and company size

Nippon India Pharma FundAxis ESG Integration Strategy Fund
Large companies29.6%49.8%
Mid companies40.8%13.1%
Small companies28.7%21.2%
Top 10 holdings57.2%49.5%
Largest sectorPharmaceuticals & Biotechnology 75%Finance 13%

Search Growth